POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
| Main Authors: | Ho, C., Breslin, M., Doust, J., Reid, Christopher, Nelson, M. |
|---|---|
| Format: | Conference Paper |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/56756 |
Similar Items
Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018)
by: Ho, C., et al.
Published: (2018)
Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017)
by: Ho, C., et al.
Published: (2017)
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)
by: Ho, C., et al.
Published: (2018)
Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020)
by: Ho, C.L.B., et al.
Published: (2020)
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)
by: Ho, C., et al.
Published: (2016)
Incidence of heart failure in 6083 elderly hypertensive patients: The Second Australian National Blood Pressure Study (ANBP2)
by: Sahle, B., et al.
Published: (2015)
by: Sahle, B., et al.
Published: (2015)
The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)
by: Ho, Chau L.B., et al.
Published: (2021)
Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
by: Dhaliwal, Satvinder, et al.
Published: (2017)
by: Dhaliwal, Satvinder, et al.
Published: (2017)
Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Ho, Chau Le Bao, et al.
Published: (2022)
by: Ho, Chau Le Bao, et al.
Published: (2022)
TEN-YEAR LEGACY EFFECTS OF BASELINE BLOOD PRESSURE TREATMENT NAIVETY IN THE SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY.
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Prediction of 10-year risk of incident heart failure in elderly hypertensive population: The ANBP2 study
by: Sahle, B., et al.
Published: (2017)
by: Sahle, B., et al.
Published: (2017)
Predicting incident heart failure in elderly hypertensive patients: the ANBP2 study
by: Sahle, B., et al.
Published: (2016)
by: Sahle, B., et al.
Published: (2016)
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016
by: Si, Si, et al.
Published: (2018)
by: Si, Si, et al.
Published: (2018)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
Kidney with lower pole simple cysts - is it an absolute contraindication for renal biopsy
by: Ng, Tze Ji, et al.
Published: (2020)
by: Ng, Tze Ji, et al.
Published: (2020)
Blood pressure lowering mechanisms of Kadukmy™ in essential hypertension
by: Mohd Zainudin, Maizura, et al.
Published: (2019)
by: Mohd Zainudin, Maizura, et al.
Published: (2019)
Novel blood pressure-lowering effect of spathulenol in rats
by: Raslan Ain-Fatin,, et al.
Published: (2024)
by: Raslan Ain-Fatin,, et al.
Published: (2024)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
by: Lonn, E., et al.
Published: (2016)
by: Lonn, E., et al.
Published: (2016)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials
by: Czernichow, S., et al.
Published: (2011)
by: Czernichow, S., et al.
Published: (2011)
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)
by: Yusuf, Salim, et al.
Published: (2016)
Fiction absolute and ethics: Tom Wolfe‘s back to blood
by: Jamshidian, Sahar, et al.
Published: (2014)
by: Jamshidian, Sahar, et al.
Published: (2014)
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
by: Lonn, Eva M., et al.
Published: (2016)
by: Lonn, Eva M., et al.
Published: (2016)
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Bennett, A., et al.
Published: (2017)
by: Bennett, A., et al.
Published: (2017)
NIGHT-TIME AMBULATORY BLOOD PRESSURE IS THE BEST PRETREATMENT BLOOD PRESSURE PREDICTOR OF 11-YEAR MORTALITY IN OLDER HYPERTENSIVES
by: Wing, L., et al.
Published: (2017)
by: Wing, L., et al.
Published: (2017)
Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals
by: Chowdhury, E., et al.
Published: (2013)
by: Chowdhury, E., et al.
Published: (2013)
A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings
by: Head, G., et al.
Published: (2010)
by: Head, G., et al.
Published: (2010)
Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
by: Wing, L., et al.
Published: (2018)
by: Wing, L., et al.
Published: (2018)
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Lipid and blood pressure lowering effects of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2023)
by: Shafie, Nurul Husna, et al.
Published: (2023)
Lipid and blood pressure lowering potential of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2020)
by: Shafie, Nurul Husna, et al.
Published: (2020)
Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)
by: Nelson, M., et al.
Published: (2010)
Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)
by: Sharman, J., et al.
Published: (2017)
by: Sharman, J., et al.
Published: (2017)
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes
by: Campbell, D., et al.
Published: (2013)
by: Campbell, D., et al.
Published: (2013)
Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)
by: Owen, A., et al.
Published: (2009)
FACTORS ASSOCIATED WITH "IN-STUDY" BLOOD PRESSURE CONTROL: FINDINGS FROM THE 2(ND) AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY
by: Chowdhury, E., et al.
Published: (2011)
by: Chowdhury, E., et al.
Published: (2011)
Nitrate-rich vegetables do not lower blood pressure in individuals with mildly elevated blood pressure: A 4-wk randomized controlled crossover trial
by: Blekkenhorst, L., et al.
Published: (2018)
by: Blekkenhorst, L., et al.
Published: (2018)
Response to "analysis and interpretation of 24-h blood pressure profiles" [1]
by: Head, G., et al.
Published: (2008)
by: Head, G., et al.
Published: (2008)
Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study
by: Gombotz, H., et al.
Published: (2016)
by: Gombotz, H., et al.
Published: (2016)
Ankle-Brachial Index determination and peripheral arterial disease diagnosis by an oscillometric blood pressure device in primary care: Validation and diagnostic accuracy study
by: Nelson, M., et al.
Published: (2012)
by: Nelson, M., et al.
Published: (2012)
Similar Items
-
Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018) -
Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017) -
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018) -
Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020) -
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)